Galapagos NV
GLPG
#4563
Rank
A$3.17 B
Marketcap
A$47.56
Share price
-0.57%
Change (1 day)
13.82%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$1.88 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are A$1.88 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$2.07 B-18.22%
2023-12-31A$2.53 B-27.2%
2022-12-31A$3.48 B-12.61%
2021-12-31A$3.98 B-18.29%
2020-12-31A$4.87 B-4.58%
2019-12-31A$5.10 B1296.68%
2018-12-31A$0.36 B-13.23%
2017-12-31A$0.42 B-11.01%
2016-12-31A$0.47 B307.18%
2015-12-31A$0.11 B21.69%
2014-12-31A$95.6 M-48.64%
2013-12-31A$0.18 B25.13%
2012-12-31A$0.14 B175.23%
2011-12-31A$54.05 M-9.18%
2010-12-31A$59.52 M7.14%
2009-12-31A$55.55 M-18.74%
2008-12-31A$68.36 M-18.29%
2007-12-31A$83.66 M-13.97%
2006-12-31A$97.25 M194.09%
2005-12-31A$33.07 M259.63%
2004-12-31A$9.19 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
A$103.10 B 5,379.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$170.93 B 8,984.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$99.40 B 5,182.97%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
A$205.49 B 10,821.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
A$0.18 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$49.55 B 2,533.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$49.08 B 2,508.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$92.26 B 4,803.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$116.88 B 6,112.06%๐Ÿ‡บ๐Ÿ‡ธ USA